Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 684319, 7 pages
http://dx.doi.org/10.1155/2015/684319
Research Article

The Use of D-Optimal Mixture Design in Optimizing Development of Okara Tablet Formulation as a Dietary Supplement

1Halal Product Research Institute, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia
2Centre of Foundation Studies for Agriculture Science, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia
3Department of Chemistry, Faculty of Science, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia
4Department of Process and Food Engineering, Faculty of Engineering, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia

Received 20 January 2015; Revised 28 May 2015; Accepted 1 June 2015

Academic Editor: Pao-Chu Wu

Copyright © 2015 Nur Izzati Mohamad Zen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Li, M. Qiao, and F. Lu, “Composition, nutrition, and utilization of okara (soybean residue),” Food Reviews International, vol. 28, no. 3, pp. 231–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Bowles and I. M. Demiate, “Physicochemical characterization of the soymilk by product-okara,” Ciência E Tecnologia de Alimentos, vol. 26, no. 3, pp. 652–659, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. E. N. Whitney and S. R. Rolfes, Understanding Nutrition, Cengage Learning, Belmont, Calif, USA, 2008.
  4. R. H. Eckel, Obesity: Mechanisms and Clinical Management, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2003.
  5. H. Wen and K. Park, Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice, John Wiley & Sons, Hoboken, NJ, USA, 2011.
  6. S. C. Gad, Pharmaceutical Manufacturing Handbook: Production and 199 Processes, John Wiley & Sons, Hoboken, NJ, USA, 2008.
  7. J. A. Seitz and G. M. Flessland, “Evaluation of the physical properties of compressed tablets. I. Tablet hardness and friability,” Journal of Pharmaceutical Sciences, vol. 54, no. 9, pp. 1353–1357, 1965. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Eriksson, Design of Experiments: Principles and Applications, MKS Umetrics AB, Malmö, Sweden, 2008.
  9. R. G. Brereton, Chemometrics: Data Analysis for the Laboratory and Chemical Plant, John Wiley & Sons, West Sussex, UK, 2003.
  10. K. H. Esbensen, D. Guyot, F. Westad, and L. P. Houmoller, “Multivariate data analysis,” in Practice: An Introduction to Multivariate Data Analysis and Experimental Design, Aalborg University, Esbjerg, Denmark, 2002. View at Google Scholar
  11. K. Valko, Separation Methods in Drug Synthesis and Purification, Elsevier, Amsterdam, The Netherlands, 2000.
  12. Stationery Office, British Pharmacopoeia 2012, Stationery Office, London, UK, 2011.
  13. A. K. Mitra, C. Mitra, D. Kwatra, and A. D. Vadlapudi, Drug Delivery, Jones & Bartlett Publishers, Burlington, Mass, USA, 2014.
  14. S. Michelson and T. Schofield, The Biostatistics Cookbook: The Most User-Friendly Guide for the Bio/Medical Scientist, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1996.
  15. G. Shlieout, K. Arnold, and G. Müller, “Powder and mechanical properties of microcrystalline cellulose with different degrees of polymerization,” AAPS PharmSciTech, vol. 3, no. 2, pp. 45–54, 2002. View at Google Scholar · View at Scopus
  16. G. Thoorens, F. Krier, B. Leclercq, B. Carlin, and B. Evrard, “Microcrystalline cellulose, a direct compression binder in a quality by design environment—a review,” International Journal of Pharmaceutics, vol. 473, no. 1-2, pp. 64–72, 2014. View at Publisher · View at Google Scholar
  17. E. Lahdenpää, M. Niskanen, and J. Yliruusi, “Crushing strength, disintegration time and weight variation of tablets compressed from three Avicel PH grades and their mixtures,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 43, no. 3, pp. 315–322, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. S. R. Elnaggar, M. A. El-Massik, O. Y. Abdallah, and A. E. R. Ebian, “Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process,” AAPS PharmSciTech, vol. 11, no. 2, pp. 645–651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Shailendra, “Natural binding agents in tablet formulation,” International Journal of Pharmaceutical & Biological Archive, vol. 3, no. 3, pp. 466–473, 2012. View at Google Scholar
  20. W. F. Smith, Experimental Design for Formulation, vol. 15 of ASA-SIAM Series on Statistics and Applied Probability, SIAM, Philadelphia, Pa, USA, 2005. View at Publisher · View at Google Scholar · View at MathSciNet
  21. M. D. O. Bastos, R. B. Friedrich, and R. C. R. Beck, “Effects of filler-binders and lubricants on physicochemical properties of tablets obtained by direct compression: a 22 factorial design,” Latin American Journal of Pharmacy, vol. 27, no. 4, pp. 578–583, 2008. View at Google Scholar · View at Scopus
  22. L. Segale, L. Maggi, S. Conti et al., “Preformulation study of fast melting tablets,” in Proceedings of the 5th World Meeting Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Geneva, Switzerland, March 2006.